vaayaa Inclusive Education
Marketing 1 min read

FTC Takes Action to Protect Americans from Higher Drug Costs in Aurobindo, Lannett Deal

Jun 19, 2026
Proposed FTC order requires divestiture of four drug products to resolve anticompetitive concerns

The Federal Trade Commission took action to protect American patients from higher drug costs by requiring Aurobindo Pharma Limited to divest four different generic drug products to complete its $250 million acquisition of Lannett Company Inc.

View Press Release

Read full article on US FTC Press →

Source: US FTC Press — US Government, Public Domain